Editorial Team

Editorial Board

Editor-in-Chief
Professor Abiodun Falodun
Professor of Pharmaceutical Chemistry
Natural product Research Group
University of Benin, Nigeria.
Email: editor.tjnpr@gmail.com;editor.tjnpr@uniben.edu
Phone: +2348073184488

 

Associate Editors:

  • Professor Dr. Dr. Peter Langer,Institute of Organic Chemistry, University of Rostock, (Germany)
  • Professor Frederick O. Ekhaise, Microbiology, University of Benin, Nigeria.
  • Professor Martins Emeje: Professor of Drug Delivery/Nanomedicine in the Department of Pharmaceutical Technology and Raw Materials Development (PT&RMD) at the National Institute of Pharmaceutical Research and Development.

Editorial Assistant:

  • Erharuyi Osayemwenre, Faculty of Pharmacy, University of Benin, Nigeria.

Board Members

  • Professor Ikhlas A. Khan, National Center for Natural Product Research, Mississippi (USA)
  • Professor Nosa Egiebor, College of Environmental Science & Forestry, State University of New York
  • Professor Samuel Qiu, South China Botanical Gardens, Chinese Academy of Sciences (China)
  • Professor Xavier Barril, De Fisicoquimica-Facultat De Farmacia Universitat de Barcelona, (Spain)
  • Professor Abiodun Ogundiani, Pharmaceutical Chemistry, OAU, Ile-Ife, (Nigeria)
  • Professor Thomas Kodadek, The Scripps Research Institute, Scripps Florida (USA)
  • Professor Anthony B Ebeigbe, Physiology, College of Medical Sciences, University of Benin, (Nigeria)
  • Professor Eric KI Omogbai, Pharmacology and Toxicology, University of Benin, Nigeria
  • Professor Dr. Udo Kragl, Institute of Organic Chemistry, University of Rostock, (Germany)
  • Professor Cyril O. Usifoh, Faculty of Pharmacy, University of Benin, Nigeria.
  • Professor Azuka C Opara, Clinical Pharmacy & Pharmacy Practice, University of Benin, (Nigeria).
  • Professor Ikhide G. Imumorin, Biological Sciences, Georgia Institute of Technology, Atlanta (USA)
  • Professor Mark T. Hamann, Medical University College, South Carolina (USA)
  • Professor Barbara Nebe, University of Rostock, (Germany)
  • Professor Anthony I. Okoh, University of Fort Hare, Alice (South Africa)
  • Professor Dr. M. Iqbal Choudhary, HEJ, University of Karachi, (Pakistan)
  • Professor Omoanghe S. Isikhuemhen, North Carolina A&T State University, (USA)
  • Professor Ezekiel Green, University of Johannesburg, (South Africa)
  • Professor John Igoli, Strathclyde Institute of Pharmacy and Biomedical Sciences, UK
  • Professor Peter Akah, Pharmacology & Toxicology, University of Nigeria, Nigeria
  • Professor H.A.B. Coker, Faculty of Pharmacy, University of Lagos (Nigeria)
  • Dr Kingsly Agho, School of Science and Health, Western Sydney University (Australia)
  • E. Igbinosa,Microbiology, University of Benin, Nigeria
  • Pius Fasinu, School of Pharmacy, Campbell University (USA)
  • Professor Larry A Walker, National Center for Natural Products Research, Mississippi, USA
  • Dr. Alireza Heidari, Faculty of Chemistry, California South University (CSU), Irvine, California, USA
  • Professor Iyere O Onoagbe, Faculty of Life Sciences, University of Benin, (Nigeria)
  • Professor Broderick Eribo, Department of Biology, Howard University, Washington DC, (USA)
  • Professor Simon Gibbons, School of Pharmacy, University College London, UK
  • Professor Masashi Mizuno, Laboratory of Food & Nutritional Chemistry, Kobe University, Japan
  • Professor FBC Okoye, Professor of Medicinal and Pharmaceutical Chemistry, Nnamdi Azikiwe University, Awka

Editorial Team Role

The editorial team is responsible for handling the peer-review process of all manuscripts. The Editor-in-Chief receives all articles submitted by authors. The Editor-in-Chief forward the articles to the Managing Editor or Assistant Editor or the Section Editor who will first decide whether the article meets the formal criteria indicated in the Author Guidelines and whether it fits within the aims and scope of the journal.

All articles shall be handled by an Editorial board member who does not have any potential conflict of interest with any of the manuscript’s authors. All Manuscripts will undergo a double-blind peer-review process, where the authors and reviewers do not know each other’s identity to ensure the highest quality of the journal.

Article handling editor will select the potential reviewers for each article and must (i) not have co-authored publications with the author and (ii) not be affiliated with the same institution as the author(s). All articles except Editorials will be sent out for peer review process and at least two reviewer comments per manuscript will be collected. Reviewers will be asked to complete their review within two weeks; however, they are allowed to extend the review period of time in order to complete and submit their report.

Peer reviewers can make one of the following recommendations for the editors to consider:
1.Accept manuscript without any change
2. Accept after minor revision (i.e., article can be accepted if the author makes the requested minor revisions)
3. Accept after minor revision (i.e., article can be accepted after major revisions have been made – the manuscript may be sent out for another peer review round)
4. Reject manuscript (i.e., the manuscript is flawed or not sufficiently novel)

When all reviewers have submitted their reports, the Editor can make one of the following editorial recommendations:
1. Accept
2. Revision
3. Reject

Revision

Formal revision may be required if the language or style is sub-standard. To facilitate rapid publication, authors are given a maximum of two weeks for minor/major revisions, with possible extensions of up to 4 weeks. Number of revisions depends upon the need for number of changes/edits needed in the article as per the instructions from the editor/reviewers to ensure quality of the article before getting them published.

Publication

If the manuscript is accepted, the author will be sent a galley proof in order for them to make any final corrections. Once this is done the manuscript will appear in the Articles in Press section of the journal’s website. All accepted peer reviewed manuscripts will be published online and are citable by the digital object identifier (DOI) assigned at the time of online publication.